| scholarly article | Q13442814 |
| P50 | author | Daniel W. Cramer | Q90007566 |
| Allison F. Vitonis | Q114314368 | ||
| P2093 | author name string | Raina N Fichorova | |
| Olivera J Finn | |||
| Kevin E Brown | |||
| Simone P Pinheiro | |||
| Todd F Hatchette | |||
| John R McKolanis | |||
| P2860 | cites work | Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer | Q28220263 |
| Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis | Q33844781 | ||
| Altered glycosylation in inflammatory bowel disease: a possible role in cancer development | Q35160089 | ||
| MUC1 and the MUCs: a family of human mucins with impact in cancer biology | Q35843504 | ||
| Glycoprotein tumor antigens for immunotherapy of breast cancer. | Q36027881 | ||
| Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells | Q36371928 | ||
| A case control study of carcinoma of the ovary | Q36683056 | ||
| Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study | Q37107494 | ||
| Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998. | Q40621352 | ||
| Mumps virus and ovarian cancer | Q41028922 | ||
| Possible role of mumps virus in the etiology of ovarian cancer | Q41612942 | ||
| Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis | Q42218524 | ||
| Risk factors for epithelial ovarian cancer in Beijing, China | Q44056477 | ||
| Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer | Q45050625 | ||
| Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer | Q45205147 | ||
| Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes | Q45747967 | ||
| Systematic Reviews in Health Care | Q56528741 | ||
| Mumps and postmenopausal ovarian cancer | Q70101795 | ||
| Mumps, menarche, menopause, and ovarian cancer | Q71020292 | ||
| Epidemiology of cancer of the ovary | Q72338559 | ||
| Epidemiologic study of malignancies of the ovaries | Q72853184 | ||
| A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis | Q73149039 | ||
| Circulating autoantibodies against purified colonic mucin in ulcerative colitis | Q73347885 | ||
| Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland | Q78014440 | ||
| Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands | Q81753319 | ||
| P433 | issue | 8 | |
| P921 | main subject | ovarian cancer | Q172341 |
| mumps | Q176741 | ||
| P304 | page(s) | 1193-1201 | |
| P577 | publication date | 2010-06-18 | |
| P1433 | published in | Cancer Causes & Control | Q325957 |
| P1476 | title | Mumps and ovarian cancer: modern interpretation of an historic association | |
| P478 | volume | 21 |
| Q47195265 | A Believer's Overview of Cancer Immunosurveillance and Immunotherapy |
| Q60463376 | Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort |
| Q33646584 | Cancer Immunoprevention and Public Health |
| Q34777634 | Epidemiologic perspective on immune-surveillance in cancer |
| Q99612796 | Fact vs Fallacy: The Anti-Vaccine Discussion Reloaded |
| Q36457087 | Host response in tumor diagnosis and prognosis: Importance of immunologists and pathologists alliance |
| Q39279256 | Human Tumor Antigens Yesterday, Today, and Tomorrow |
| Q85560832 | In Reply |
| Q37063097 | In vivo and in vitro studies on apoptosis in OSE cells and inclusion cysts of pregnant heifers |
| Q33555975 | Infections and cancer: the "fifty shades of immunity" hypothesis |
| Q33551458 | Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance |
| Q38570769 | MUC1 (CD227): a multi-tasked molecule |
| Q36508191 | MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study |
| Q36597345 | Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients |
| Q37137385 | Natural and Induced Humoral Responses to MUC1. |
| Q37248635 | Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk |
| Q35886454 | Regulatory considerations for clinical development of cancer vaccines |
| Q35676052 | The Epidemiology of Endometrial and Ovarian Cancer |
| Q49566629 | The dawn of vaccines for cancer prevention |
| Q96640451 | The role of innate immunity in the protection conferred by a bacterial infection against cancer: study of an invertebrate model |
| Q57177129 | Therapeutic cancer vaccine: building the future from lessons of the past |
| Q24597894 | Thunder and lightning: immunotherapy and oncolytic viruses collide |
| Q89884852 | Villains or heroes? The raison d'être of viruses |
Search more.